Reacción #1605834

ord-d8f0727fafe34ea1a62bc306ec935c3f

Ecuación de reacción

O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1
aripiprazole
CCN(CC)CC
triethylamine
O=C=NCc1ccccc1
benzyl isocyanate
O=C1CCc2ccc(OCCCCN3CCN(c4cccc(Cl)c4Cl)CC3)cc2N1C(=O)NCc1ccccc1
N-benzyl-7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-2-oxo-3,4-dihydroquinoline-1(2H)-carboxamide

Disolventes

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    OtroThe reaction was quenched with water
  2. 2
    Extracciónextracted with dichloromethane (3×20 mL)
  3. 3
    Lavadowashed with brine (20 mL)
  4. 4
    Secadodried over MgSO4
  5. 5
    Concentraciónconcentrated
  6. 6
    OtroThe residue was purified by column chromatography on silica eluting with 0-10% tetrahydrofuran in ethyl acetate
  7. 7
    OtroThe product was triturated in heptane
  8. 8
    Otroto remove aliphatic impurities
  9. 9
    Filtraciónfiltered
  10. 10
    Otrodried
  11. 11
    Otroto afford Compound-79 (0.575 g) as a colorless solid

Procedimiento

To a solution of aripiprazole (1.5 g, 3.35 mmol) in dichloromethane (33 mL) was added triethylamine (0.56 mL, 4.01 mmol) and benzyl isocyanate (0.82 mL, 6.69 mmol). The reaction was stirred at room temperature for 48 hours. The reaction was quenched with water and extracted with dichloromethane (3×20 mL). The organics were combined, washed with brine (20 mL), dried over MgSO4 and concentrated. The residue was purified by column chromatography on silica eluting with 0-10% tetrahydrofuran in ethyl acetate. The product was triturated in heptane to remove aliphatic impurities and then filtered and dried to afford Compound-79 (0.575 g) as a colorless solid.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US09072788B2uspto-grants-2015_07